Introduction

Brachial plexus avulsion (BPA) is a major injury, usually the result of high-velocity trauma occurring in a motorcycle accident setting. One of the disabling sequelae of BPA, apart from paralysis and anaesthesia of the affected limb, is severe neuropathic pain that can be unresponsive to conservative and surgical management options, including analgesics, brachial plexus re-implantation and spinal cord stimulation. Surgical lesioning of the dorsal root entry zone (DREZ), a neuroanatomical site considered important in spinal nociceptive processing, can be performed to relieve refractory pain in patients with BPA.

Originally developed in the 1970s [1, 2], DREZ lesioning has been used for a wide range of disorders featuring pain and spasticity. The predominant indication is to alleviate BPA pain, for which the success rate is in the region of 75% [3,4,5,6,7,8,9]. The main DREZ lesioning modalities in use are the combined microknife and bipolar coagulation procedure (known as ‘microsurgical DREZotomy’) and radiofrequency lesioning [3]. Whilst the ‘microsurgical DREZotomy’ technique continues to be widely used and has good long-term outcomes, radiofrequency lesioning has been used in the largest reported number of patients, and it is this modality which was used in the present study. In this study, we describe post-operative outcomes for patients that underwent DREZ lesioning for BPA pain.

Methods

Patient population

Between June 2006 and June 2019, a total of 16 patients with BPA were listed for DREZ lesioning at our centre under the senior author (D.C.). One patient had an intra-operative myocardial infarction before lesioning could begin, meaning that 15 patients received DREZ lesioning. One further patient had no documented follow up or contact details. The relevant clinical characteristics of all 16 patients are summarised in Table 1. The study was registered with and approved by the hospital Clinical Audit Service governance pathway (201920-16). No identifiable data was used and individual written patient consent was therefore waived.

Table 1 Patient characteristics.

Surgical technique

Via a midline posterior cervical skin incision and unilateral subperiosteal dissection, C5–T1 hemilaminectomies were performed. A paramedian cranio-caudal durotomy was made, exposing the hemi-cord and DREZ. Lissauer’s tract was identified by observing for pial disruption of avulsed rootlets and identifying any intact rootlets above or below the avulsed levels. A radiofrequency generator (Cosman, Boston Scientific), set at 70 °C and 15 s per lesion, was used to create serial lesions along the posterolateral sulcus, spaced 2 mm apart and ~2 mm deep.

Patient assessment

At review, patients were asked to retrospectively quantify pre-operative pain as well as post-operative (i.e. current) pain using visual analogue scale (VAS) scoring. Any persisting post-operative complications were documented. Relatives were interviewed in two cases where the patient was cognitively impaired, preventing VAS scoring of pain but permitting recording of complications. Documentation from outpatient clinic visits was used for four patients who were uncontactable. Median duration of post-operative telephone follow-up was 37 months (range 11–145 months).

Assessment of pain relief

The degree of pain relief after DREZ lesioning was qualitatively graded as ‘complete’ (2), ‘significant’ (1), ‘insignificant’ (0) or ‘worse’ (–1) at each post-operative time point available, including serial outpatient clinic visits and—in the ten cases for which this was possible—based on VAS score at final telephone follow-up. For the ten patients in whom VAS scores were obtained, this provided a standardised numerical comparison of pre- and post-operative pain.

Statistical analysis

The Wilcoxon signed-rank test (SPSS, IBM Corporation) was used to determine the statistical significance of post-operative change in VAS.

Results

Pain relief

Pain relief for the 14 patients in our series is summarised in Table 2, qualitatively graded over time as ‘worse’, ‘insignificant’, ‘significant’ and ‘complete’. At the latest follow-up point, four patients (29%) reported ‘complete’ pain relief, six (43%) reported ‘significant’ pain relief and four (29%) reported ‘insignificant’ pain relief.

Table 2 Pain relief grading over time.

In the ten patients providing VAS scores on telephone follow-up, the median retrospective VAS prior to DREZ lesioning was 9.1 (range 7–10), compared to a median VAS of 3.5 (range 0–9) at most recent review, representing a statistically significant reduction in BPA pain level (p < 0.005, Wilcoxon signed-rank test) (see Fig. 1). Duration of pre-operative BPA pain (calculated as age at DREZ lesioning minus age at BPA) was correlated with the degree of pain relief following DREZ lesioning (calculated as pre-operative VAS minus post-operative VAS) when an outlier of case 1 was excluded from the analysis (correlation coefficient = 0.41) (see Fig. 2).

Fig. 1: Visual analogue scale (VAS) scores before dorsal root entry zone (DREZ) lesioning and at final follow-up.
figure 1

Median scores for our patient series are presented at far right. **p < 0.005 Wilcoxon signed-rank test.

Fig. 2: The relationship between pre-operative duration of brachial plexus avulsion (BPA) pain and effectiveness of dorsal root entry zone (DREZ) lesioning.
figure 2

All patients with both pre- and post-operative visual analogue scale (VAS) scores are included except case 1.

Complications

There were no procedure-related mortalities amongst included patients. The most severe complication was an intra-operative non-fatal myocardial infarction at the time of initial muscle dissection, leading to abandonment of the lesioning stage of the procedure (case 16).

Other complications are represented in Fig. 3. Eight of the 14 patients (57%) that received DREZ lesions encountered significant motor and/or sensory complications persisting until most recent review. Sensory complications were overall more prevalent, most commonly affecting the lower limb ipsilateral to the DREZ lesion. Persistent sexual dysfunction as a result of DREZ lesioning was noted in one patient.

Fig. 3: Motor and sensory complications after dorsal root entry zone (DREZ) lesioning.
figure 3

Details of complications persisting at follow-up are tabulated at left for the eight patients experiencing complications, with pictorial representations depicted at right.

Discussion

Key findings

DREZ lesioning conferred a degree of pain relief in the majority (71%) of patients in this series: four patients (29%) had complete BPA pain relief at last follow-up, whilst six patients (43%) described partial pain relief. In four patients (29%), DREZ lesioning did not achieve any pain relief, or its benefit was negligible. In keeping with other studies [9,10,11], sensory complications (paraesthesia, dysaesthesia, hypoaesthesia and sensory ataxia) were more commonly encountered than motor deficits and sphincter/sexual dysfunction. Complications in DREZ lesioning can arise due to the close proximity of ascending and descending white matter tracts, with a degree of thermal propagation emanating from the radiofrequency lesioning probe. The frequently scarred and deformed gross appearance of the spinal cord following BPA necessitates careful identification of the target site [12].

The pain profiles in patients with BPA are highly variable, with differences in location, pain characteristic and pain severity [13]. Patients who experienced the greatest benefit from DREZ lesioning were generally those that had predominantly paroxysmal BPA pain rather than continuous or phantom components, though these too were relieved in some, as previously described [14]. Furthermore, with the exception of case 1 (whose DREZ lesioning was performed 46 years after the original injury, and whose BPA pain proved resistant to nerve transfers, amputation and deep brain stimulation), pre-operative duration of BPA pain was positively correlated with the degree of pain relief experienced after DREZ lesioning. Whilst previous studies reporting similar findings [7, 11, 15] have not provided pathophysiological explanations for this phenomenon, Du et al. recently hypothesised that increasing dorsal horn neuronal hyperactivity may arise over time with disinhibition of Lissauer’s tract []. This trend may also reflect more realistic expectations of surgical outcome in patients with a prolonged history of severe chronic pain, repeated visits to healthcare facilities resulting in better health literacy [16].

Selected cases of interest

A patient demonstrating the efficacy of DREZ lesioning for BPA pain is case 8, whose left-sided BPA at age 35 resulted in severe continuous pain shooting down to the left wrist, as well as paralysis of the left arm and hypoaesthesia distal to the forearm. The pain was refractory to proximal brachial plexus re-implantation and a variety of pharmacological agents (including pregabalin, nortriptyline, duloxetine, amitriptyline and repeated cervical injections). DREZ lesioning 6 years after BPA provided complete pain relief that was still persisting at 26 months post-operatively, with no analgesic requirement. No complications were associated with the procedure. The pain-freedom enabled the patient to have an ‘enjoyable’ life without impediment to activities of daily living.

By contrast, case 4 represented a poor outcome following DREZ lesioning. Right-sided BPA at age 21 resulted in constant ‘electrical’ pain that neither analgesic therapy with gabapentin, fentanyl, oxycodone and amitriptyline, nor brachial plexus re-implantation and subsequent above-elbow amputation was effective at relieving. The amputation resulted in additional painful sequelae of stump and phantom pain. The patient was listed for DREZ lesioning 12 years post-injury. After initial decrease in neuropathic pain severity to a ‘manageable’ level (documented at clinic review 4 months post-operatively), the pain returned to the same pre-operative level at final clinic follow-up 16 months post-operatively. Weakness of the contralateral elbow and transient ipsilateral shoulder pain were noted to have resulted from DREZ lesioning. The significant intra-operative finding in this case was extensive arachnoiditis and distortion of the spinal cord without clear demarcation of the DREZ, which made it difficult to accurately lesion Lissauer’s tract.

Case 7 was notable for demonstrating variable improvement in pain components. Left-sided BPA at the age of 27 gave rise to a continuous VAS 7 pain component interspersed around thrice daily with a paroxysmal ‘breakout’ VAS 10 element in spite of high-dose amitriptyline and pregabalin. Brachial plexus re-implantation resulted in some improved motor function of biceps and partial restoration of sensation in the affected arm but insignificant pain relief. The patient’s persisting BPA pain culminated in DREZ lesioning 20 years after the original accident. At final telephone follow-up 57 months post-operatively, the patient reported that DREZ lesioning had completely abolished the paroxysmal breakout pain (VAS 0), but that the continuous ‘crushing’ pain remained, albeit with an appreciable decrease of this component to a VAS score of 4. No complications had resulted from the procedure and the analgesic requirement was reduced to pregabalin monotherapy. The pain relief resulting from DREZ lesioning enabled the patient to work, resulting in a significantly better quality of life.

Limitations

The small sample size and retrospective nature of our study hampers the drawing of statistically significant conclusions. A prospective study design would enable more accurate quantification of pre- and post-operative analgesic use, an important factor to consider in BPA pain.

Conclusion

DREZ lesioning is effective at relieving pain in the majority of patients with intractable BPA pain, and can be recommended when pharmacological and conservative management prove to be insufficient. A significant proportion of patients experience persistent post-operative complications, the majority of which are of a sensory nature, but these are often outweighed by the gains in pain relief and quality of life offered by DREZ lesioning.